General synthesis of 8
Compound 3, 40 mg (0.12 mmol), the second aldehyde to be used (0.30 mmol), and βalanine, 16 mg (0.18 mmol) were taken up in 1.2 mL methanol and 1.2 mL acetonitrile. 0.05 mL acetic acid was added and the mixture was heated in a sealed tube with microwave irradiation for 10 minutes at 80 °C. The resulting solution was cooled to 0 °C and 45 mg (0.18 mmol) chloranil was added. The mixture was stirred at room temperature for one hour and then concentrated under reduced pressure. The residue was dissolved in 0.8 mL acetic acid and 1.6 mL acetonitrile and heated in a sealed tube with microwave irradiation for 10 minutes at 140 °C. The solution was neutralized with saturated aqueous NaHCO 3 , saturated with NaCl(s), and then extracted with CH 2 Cl 2 . The organic extracts were concentrated under reduced pressure and the residue was adsorbed onto silica and purified with silica gel chromatography using heptane: ethyl acetate 4:1 → 1:2 as eluent.
S4
(R)-2,3-Dihydro-8,10-Diphenyl-5-oxo-thiazolo[3,2-b][2,7]naphthyridine-3-carboxylic acid methyl ester (8a) By following the general synthesis of 8, using 32 mg benzaldehyde as the second aldehyde, 39 mg (78 %) 8a was obtained.
[α] D -155 (c 0.5, DMSO); IR λ 1735, 1661, 1591; 1 H NMR (CDCl 3 ) δ 9.60 (s, 1H), 7.93-7.87 (m, 2H), 7.56-7.46 (m, 3H), 7.46-7.37 (m, 6H), 5.79 (dd, J = 8.3, 2.1 Hz, 1H), 3.86 (s, 3H), 3.71 (dd, J = 11.6, 8.3 Hz, 1H), 3.52 (dd, J = 11.6, 2.1 Hz, 1H); 13 C NMR (CHCl 3 ) δ 168. 6, 160.4, 159.6, 151.4, 145.6, 143.9, 138.8, 134.9, 130.5, 130.1, 129.6, 129.4, 129.2, 128.8 (3C), 127.5 (2C), 117.2, 112.7, 111.6, 63.1, 53.5, 31.5 ; HRMS calcd for C 24 H 18 N 2 NaO 3 S [M+Na]: 437.0936, found: 437.0935.
(R)-8-(4-Cyanophenyl)-2,3-dihydro-5-oxo-10-phenyl-thiazolo[3,2b][2,7] naphthyridine-3-carboxylic acid methyl ester (8b) By following the general synthesis of 8, using 40 mg 4-cyanobenzaldehyde as the second aldehyde, 39 mg (73 %) 8b was obtained.
[α] D -174 (c 1.0, CHCl 3 ); IR λ 2225, 1746, 1660, 1586; 1 H NMR (CDCl 3 ) δ 9.60 (s, 1H), 8.00 (d, J = 8.3 Hz, 2H), 7.69 (d, J = 8.3 Hz, 2H), 3H), 1H), 2H), 1H) , 3.86 (s, 3H), 3.79-3.69 (m, 1H), 3.54 (dd, J = 11.7, 2 Hz, 1H); 13 C NMR (CDCl 3 ) δ 168. 4, 160.2, 157.2, 151.7, 146.6, 144.0, 142.9, 134.6, 132.6 (2C), 130.5, 130.1, 129.5, 129.4, 129.0, 128.0 (2C), 118.7, 117.9, 113.5, 113.0, 111.5, 63.1, 53.6, 31.6 ; HRMS calcd for C 25 H 17 N 3 NaO 3 S [M+Na]: 462.0888, found: 462.0884.
(R)-8-(1,3-Benzodioxol-5-yl)-2,3-dihydro-5-oxo-10-phenyl-thiazolo[3,2b][2,7] naphthyridine-3-carboxylic acid methyl ester (8c) By following the general synthesis of 8, using 46 mg 1,3-benzodioxole-5-carbaldehyde as the second aldehyde, 43 mg (77 %) 8c was obtained.
[α] D -146 (c 1.0, CHCl 3 ); IR λ 1745, 1651, 1585; 1 H NMR (CDCl 3 ) δ 9.52 (s, 1H), 7.56-7.45 (m, 3H), 7.45-7.36 (m, 4H), 7.31-7.28 (m, 1H), 6.86-6.80 (m, 1H), 5.79 (s, 2H), 5.80-5.73 (m, 1H) , 3.85 (s, 3H), 3.75-3.65 (m, 1H), 3.55-3.47 (m, 1H); 13 C NMR (CDCl 3 ) δ 168. 6, 160.5, 159.1, 151.3, 149.1, 148.3, 145.5, 143.9, 134.9, 133.2, 130.5, 130.1, 129.4, 129.3, 128.8, 121.9, 116.9, 111.9, 111.7, 108.6, 107.7, 101.5, 63.1, 53.5, 31.6 ; HRMS calcd for C 25 H 18 N 2 NaO 5 S [M+Na]: 481.0834, found: 481.0830.
(R)-2,3-Dihydro-5-oxo-10-phenyl-8-(1-propyl)-thiazolo[3,2-b][2,7]naphthyridine-3carboxylic acid methyl ester (8d)
By following the general synthesis of 8, using 22 mg butyraldehyde as the second aldehyde, 31 mg (67 %) 8d was obtained.
[α] D -191 (c 1.0, CHCl 3 ); IR λ 1747, 1653, 1589; 1 H NMR (CDCl 3 ) δ 9.47 (s, 1H), 7.55-7.43 (m, 3H), 7.40-7.31 (m, 2H) , 6.84 (s, 1H), 5.76 (dd, J = 8.3, 2.2 Hz, 1H), 3.85 (s, 3H), 3.68 (dd, J = 11.7, 8.3 Hz, 1H), 3.5 (dd, J = 11.7, 2.2 Hz, 1H), 2.73 (t, J = 7.6 Hz, 2H), 1.77-1.63 (m, 2H), 0.92 (t, J = 7.4 Hz, 3H); 13 C NMR (CDCl 3 ) δ 168. 7, 165.5, 160.6, 151.2, 145.1, 143.6, 135.1, 130.5, 130.2, 129.4, 129.2, 128.7, 116.8, 114.7, 111.4, 63.1, 53.6, 40.8, 31.6, 23.2, 13.9 ; HRMS calcd for C 21 H 20 N 2 NaO 3 S [M+Na]: 403.1092, found: 403.1094. 4, 168.6, 160.6, 151.1, 145.0, 143.7, 135.1, 130.5, 130.1, 129.3, 129.1, 128.7, 116.9, 112.7, 111.5, 63.0, 53.5, 36.7, 31.5, 22.4 (2C) ; HRMS calcd for C 21 H 20 N 2 NaO 3 S [M+Na]: 403.1092, found: 403.1102.
S6
(R)-2,3-Dihydro-8-(4-methyl-5-imidazolyl)-5-oxo-10-phenyl-thiazolo[3,2-b][2,7] naphthyridine-3-carboxylic acid methyl ester (8f) By following the general synthesis of 8, using 33 mg 4-methyl-5imidazolcarboxaldehyde as the second aldehyde, 29 mg (56 %) 8f was obtained. For this compound 0.5 % triethylamine was added to the eluent during silica gel chromatography.
[α] D -270 (c 1.0, CHCl 3 ); IR λ 1740, 1653, 1585; 1 H NMR (CDCl 3 ) δ 9.44 (s, 1H), 7.53 (s, 1H), 7.50-7.33 (m, 6H), 5.77 (dd, J = 8.3, 2.1 Hz, 1H), 3.85 (s, 3H), 3.75-3.65 (m, 1H), 3.51 (dd, J = 11.7, 2.1 Hz, 1H), 2.39 (s, 3H); 13 C NMR (CDCl 3 ) δ 168. 7, 160.6, 153.5, 151.2, 145.3, 143.8, 134.9, 134.4 (2C), 130.4, 130.0, 129.3, 129.1 (2C), 128.8, 116.1, 111.8, 111.4, 63.0, 53.6, 31.6, 14.1; HRMS calcd for C 22 H .19-7.12 (m, 1H), 7.11-7.03 (m, 1H), 5.82-5.76 (m, 1H), 3.87 (dd, J = 11.8, 8.9 Hz, 1H), 3.78 (s, 3H), 3.59 (dd, J = 11.8, 1.9 Hz, 1H); 13 C NMR (DMSO-d 6 ) δ 168. 8, 159.3, 157.2, 150.4, 146.3, 143.0, 137.2, 134.8, 130.2 (2C), 129.3, 129.1, 128.6, 127.7, 124.8, 121.9, 120.4, 120.1, 114.9, 114.8, 112.3, 109 .6 (2C, splitted), 62.6, 53.1, 30.8; HRMS calcd for C 26 H 19 N 3 NaO 3 S [M+Na]: 476.1045, found: 476.1047.
(R)-2,3-Dihydro-8-(2-methyl-6-pyridyl)-5-oxo-10-phenyl-thiazolo[3,2-b][2,7] naphthyridine-3-carboxylic acid methyl ester (8h)

S7
By following the general synthesis of 8, using 37 mg 6-methyl-2-pyridinecarbaldehyde as the second aldehyde, 37 mg (71 %) 8h was obtained.
[α] D -255 (c 1.0, CHCl 3 ); IR λ 1747, 1661, 1583; 1 H NMR (CDCl 3 ) δ 9.58 (s, 1H), 8.19 (d, J = 7.7 Hz, 1H), 8.16 (s, 1H), 7.66 (t, J = 7.7 Hz, 1H), 7.56-7.37 (m, 5H), 7.12 (d, J = 7.7 Hz, 1H), 5.77 (dd, J = 8.3, 2.1 Hz, 1H), 3.84 (s, 3H), 3.69 (dd, J = 11.6, 8.3 Hz, 1H), 3.50 (dd, J = 11.6, 2.1 Hz, 1H), 2.50 (s, 3H); 13 C NMR (CDCl 3 ) δ 168. 6, 160.5, 158.5, 158.2, 154.9, 151.1, 145.5, 143.9, 137.1, 135.0, 130.5, 130.3, 129.2, 129.1, 128.7, 123.8, 119.1, 118.2, 113.7, 112.2, 63.1, 53.5, 31.5, 24.6 ; HRMS calcd for C 24 H 19 N 3 NaO 3 S [M+Na]: 452.1045, found: 452.1041.
3,5-Dibromo-2-methoxy-4-methyl-pyridine (10)
2-Methoxy-4-methylpyridine, 985 mg (8.00 mmol) and sodium acetate, 1968 mg (23.99 mmol) were taken up in 8.0 mL acetic acid. 1.15 mL (22.4 mmol) Br 2 was added and the mixture was stirred at 80 °C over night. The reaction was allowed to cool to room temperature and then quenched with 10% NaOH (aq.) and saturated aqueous Na 2 SO 3 . The aqueous phase was extracted with diethyl ether and the organic phase was concentrated under reduced pressure. The residue was filtrated through a short silica gel column using CH 2 Cl 2 as eluent. 2175 mg (97%) of compound 10 was obtained as a white solid. IR λ 1366; 1 H NMR (CDCl 3 ) δ 8.05 (s, 1H), 3.93 (s, 3H), 2.48 (s, 3H); 13 C NMR (CDCl 3 ) δ 159. 5, 148.2, 145.6, 114.6, 109.7, 54.8, 23.4 ; LC-MS calcd for C 7 H 8 Br 2 NO [M+H]: 280, found: 280
5-Bromo-2-methoxy-4-methyl-pyridine-3-carbaldehyde (11)
Compound 10, 787 mg (2.80 mmol) was dissolved in 11.2 mL diethyl ether and cooled to -70 °C. To the resulting slurry was added 1.80 mL (2.88 mmol) 1.6 M BuLi(hexanes). After 15 minutes of stirring, 0.35 mL (5.7 mmol) methyl formate was added and the mixture was stirred another 30 minutes at -70 °C before it was quenched with aqueous saturated NaHCO 3 . The aqueous phase was extracted with diethyl ether and the organic phase was concentrated under reduced pressure. The residue was passed through a column of silica gel using hexane: CH 2 Cl 2 2:1 as eluent. The resulting solid (565 mg) was approximately 95 % pure by NMR and was further purified by repeated recrystallization from tert-butylmethyl ether: hexane 1:1 (~1 mL / mmol) with recovery and recrystallization of the mother liquor. Compound 11, 510 mg (79 %) was obtained as small colorless needles. M.p 89. 7-90.4 
2-Methoxy-4-methyl-5-phenyl-pyridine-3-carbaldehyde (12)
Compound 11, 345 mg (1.50 mmol), Pd(OAc) 2 , 3.4 mg (0.015 mmol), phenylboronic acid, 274 mg (2.25 mmol) and potassium fluoride, 131 mg (2.25 mmol) was dissolved in 9.0 ml of a 2:1 mixture PEG-400:MeOH. The solution was vigorously stirred in air for 1.5 hour. The reaction mixture was quenched by addition of water and then extracted with diethyl ether. The organic phase was concentrated under reduced pressure and the resulting residue was purified with silica gel chromatography using heptane: CH 2 Cl 2 6:1 → 0:1 as eluent. Compound 12, 320 mg (94 %) was obtained as colorless oil that solidified upon cooling. IR λ 1681; 1 H NMR (CDCl 3 ) δ 10.55 (s, 1H), 8.11 (s, 1H), 7.41-7.29 (m, 3H), 7.24-7.17 (m, 2H) , 4.02 (s, 3H), 2.43 (s, 3H); 13 C NMR (CDCl 3 ) δ 191. 7, 164.9, 151.1, 149.7, 137.1, 133.3, 129.7 (2C), 128.4 (2C), 127.6, 116.8, 53.8, 17.9; HRMS calcd for C 14 H 13 NNaO 2 [M+Na]: 250.0844, found: 250.0850.
4-Methyl-2-oxo-5-phenyl-1,2-dihydro-pyridine-3-carbaldehyde (13)
Compound 12, 227 mg (1.00 mmol) was dissolved in 10 ml acetic acid. 0.29 ml 47% aqueous hydrobromic acid was added and the solution was stirred at 40 °C over night. The reaction was quenched by cautiously pouring it into saturated aqueous NaHCO 3 . The aqueous mixture was extracted with CH 2 Cl 2 and the organic phase was concentrated under reduced pressure. The resulting residue was purified with silica gel chromatography using CH 2 Cl 2 : EtOAc 1:0 → 1:4 as eluent. 
4,6-Diphenyl-2H-[2,7]naphthyridine-1-one (14a)
In analogy with the conversion of 3 to 8, Compound 13, 32 mg (0.15 mmol), benzaldehyde, 40 mg (0.38 mmol), and β-alanine, 20 mg (0.22 mmol) was taken up in 1.5 mL methanol and 1.5 mL acetonitrile. 0.06 mL acetic acid was added and the mixture was heated in a sealed tube at 80 °C for 10 minutes using microwave irradiation. The resulting solution was cooled to 0 °C and 55 mg (0.22 mmol) chloranil was added. The mixture was stirred at room temperature for one hour and then concentrated under reduced pressure. The residue was taken up in 2.0 mL acetonitrile and 1.0 mL acetic acid and heated in a sealed tube at 140 °C for 10 minutes using microwave irradiation. The solution was neutralized with saturated aqueous NaHCO 3 , saturated with NaCl(s), and then extracted with CH 2 Cl 2 . The combined organic extracts were concentrated under reduced pressure and the residue was adsorbed onto silica and purified with silica gel chromatography using CH 2 Cl 2 : ethyl acetate 9:1→1:2 gave 24 mg (54 % 8, 157.7, 150.7, 142.8, 138.1, 134.8, 133.3, 129.7, 129 .6 (2C), 128.9 (4C), 127.7, 126.9 (2C), 119.4, 116.0, 112.9; HRMS calcd for C 20 H 14 N 2 NaO [M+Na]: 321.1004, found: 321.0993.
5-Methyl-4-phenyl-2H-[2,7]naphthyridine-1-one (14b)
Compound 13, 32 mg (0.15 mmol), 37 % aqueous formaldehyde, 30 mg (0.37 mmol), and β-alanine, 20 mg (0.22 mmol) was taken up in 1.5 mL methanol and 1.5 mL acetonitrile. 0.06 mL acetic acid was added and the mixture was heated in a sealed tube at 80 °C for 10 minutes using microwave irradiation. The resulting solution was concentrated under reduced pressure and the residue was taken up in 2.0 mL acetonitrile and 1.0 mL acetic acid and heated in a sealed tube at 140 °C for 10 minutes using microwave irradiation. The solution was neutralized with saturated aqueous NaHCO 3 , saturated with NaCl(s), and then extracted with CH 2 Cl 2 . The combined organic extracts were concentrated under reduced pressure and the residue was purified with silica gel chromatography using CH 2 Cl 2 : ethyl acetate: methanol 50:50:0 → 50:50:1 as eluent. Compound 14b, 19 mg (54 %) was obtained as a white solid. IR λ 1651; 1 H NMR (DMSO-d 6 ) δ 11.77 (bs, 1H), 9.29 (s, 1H), 8.46 (s, 1H), 7.46-7.39 (m, 3H), 7.37-7.30 (m, 2H), 7.17 (s, 1H), 1.75 (s, 3H); 13 C NMR (DMSO-d 6 ) δ 161. 2, 153.3, 148.8, 140.5, 138.5, 133.8, 130.3 (2C), 128.0 (2C), 127.6, 127.1, 120.7, 116.0, 19.3 ; HRMS calcd for C 15 H 12 N 2 NaO [M+Na]: 259.0847, found: 259.0847. -2H-[2,7]naphthyridine-1-one (6 -Lophocladine A) Compound 13, 32 mg (0.15 mmol), and β-alanine, 40 mg (0.45 mmol) were taken up in 1.5 mL methanol and 1.5 ml acetonitrile. 60 µL ethyl oxoacetate (50 % in toluene) (0.30 mmol) and 0.06 mL acetic acid were added and the mixture was heated in a sealed tube at 80 °C for 10 minutes using microwave irradiation. The reaction was cooled to 0 °C and 111 mg (0.45 mmol) chloranil was added. The mixture was stirred at room temperature over night. The reaction mixture was concentrated twice from ethanol and then taken up in 0.9 ml tetrahydrofuran 0.9 mL 2.0 M aqueous NaOH. The mixture was stirred at room temperature for 3 hours and then concentrated. The residue was taken up in 2.0 mL acetonitrile and 1.0 mL acetic acid and heated in a sealed tube at 140 °C for 10 minutes using microwave irradiation. The reaction mixture was diluted with CH 2 Cl 2 and a small amount of methanol and washed with a mixture of saturated aqueous NaHCO 3 and brine. The aqueous phase was extracted with CH 2 Cl 2 and the combined organic phases were then concentrated under reduced pressure. The resulting residue was purified with silica gel chromatography using CH 2 Cl 2 : EtOAc 1:0 → 0:1 as mobile phase. Lophocladine A (6), 5.5 mg (16 %) was obtained as a white solid after lyophalization from acetonitrile:water. NMR-data (DMSO-d 6 ) was in agreement with previously published data. S2
S10
Synthesis of Lophocladine A (6)
4-Phenyl
Synthesis of tetrahydro naphthyridones 15. General procedure A. 15
Compound 13, 32 mg (0.15 mmol), a second aldehyde, (0.30 mmol), and a primary amine (0.45 mmol) were dissolved in 1.5 mL methanol and 1.5 mL acetonitrile. 0.06 mL acetic acid was added and the solution was heated in a sealed tube at 80 °C for 10 minutes using microwave irradiation. The reaction was cooled to 0 °C and 40 mg NaBH 4 was added. The reaction was stirred at rt one hour and then quenched by addition of saturated aqueous NaHCO 3 and brine. The aqueous phase was extracted with CH 2 Cl 2 and the organic extract was concentrated under reduced pressure. The resulting residue was purified with silica gel chromatography using CH 2 Cl 2 : MeOH 97:3 → 94:6. S11 -7-methyl-4-phenyl-5,6,7,8-tetrahydro-2H-[2,7] naphthyridine-1-one (15a) Compound 15a, 21 mg (50 %) was obtained by following general procedure A for synthesis of tetrahydro naphthyridones using 22 mg isobutyraldehyde as the second aldehyde and 0.28 mL 1.6 M methylamine in methanol as amine. (The amount of methanol added as solvent was adjusted to 1.22 mL.) IR λ 1653; 1 H NMR (CDCl 3 ) δ 13.18 (bs, 1H), 7.42-7.31 (m, 3H), 7.25-7.20 (m, 2H) 8, 146.5, 136.5, 130.5, 129.6 (2C), 128.6 (2C), 127.6, 124.4, 122.8, 63.5, 53.7, 40.3, 28.2, 26.6, 20.2, 16.3 ; HRMS calcd for C 18 H 22 N 2 NaO [M+Na]: 305.1630, found: 305.1623. Diphenyl-5,6,7,8-tetrahydro-2H-[2,7] naphthyridine-1-one (15b) Compound 15b, 9 mg (20 %) was obtained by following general procedure A for synthesis of tetrahydro naphthyridones using 32 mg benzaldehyde as the second aldehyde and 35 mg ammonium acetate as amine. (The amount of acetic acid added was adjusted to 34 µl.) IR λ 1643; 1 H NMR (CDCl 3 ) δ 7.38-7.26 (m, 8H), 7.25-7.21 (m, 3H), 4.28 (d, J = 17.3 Hz, 1H), 4.01 (d, J = 17.3 Hz, 1H), 3.85 (dd, J = 10.4, 3.5 Hz, 1H), 2.80-2.69 (m, 1H), 2.60-2.52 (m, 1H); 13 C NMR (CDCl 3 ) δ 162. 8, 146.8, 143.7, 136.3, 130.6, 129 .6 (2C), 128.8 (2C), 128.6 (2C), 127.8, 127.6, 126.8 (2C), 125.4, 123.0, 57.8, 45.2, 37.3; HRMS calcd for C 20 30 mmol) , and a primary amine (0.45 mmol, 3 equiv.) were dissolved in 1.5 mL methanol and 1.5 mL acetonitrile. 0.15 mL formic acid was added and the solution was heated in a sealed tube at 100 °C for 15 minutes using microwave irradiation. The reaction was neutralized with saturated aqueous NaHCO 3 and extracted with CH 2 Cl 2 . The organic phase was concentrated under reduced pressure and the residue was purified with silica gel chromatography using CH 2 Cl 2 : MeOH 1:0 → 95:5. Methyl-4,6-diphenyl-5,6,7,8-tetrahydro-2H-[2,7] naphthyridine-1-one (15c) Compound 15c, 32 mg (67 %) was obtained by following general procedure B for synthesis of tetrahydro naphthyridones using 0.28 mL 1.6 M MeNH 2 in methanol as amine. (The amount of methanol added as solvent was adjusted to 1.22 mL.) IR λ 1644; 1 H NMR (CDCl 3 ) δ 13.44 (bs, 1H), 9H), 2H), 4.17 (d, J = 17.2 Hz, 1H), 3.36 (d, J = 17.2 Hz, 1H), 3.27 (dd, J = 10.0, 3.6 Hz, 1H), 2.92 (dd, J = 17.7, 10.0 Hz, 1H), 2.61 (dd, J = 17.7, 3.6 Hz, 1H), 2.19 (s, 3H); 13 C NMR (CDCl 3 ) δ 162. 7, 146.2, 142.0, 136.3, 130.7, 129.5 (2C), 128.8 (2C) , 128.6 (2C), 128.1 (2C), 127. 7, 127.6, 124.7, 122.4, 65.5, 54.3, 43.4, 37.9 ; HRMS calcd for C 21 H 21 N 2 O [M+H]: 317.1654, found: 317.1654. Hydroxy-ethyl)-4,6-diphenyl-5,6,7,8-tetrahydro-2H-[2,7] naphthyridine-1-one (15d) S13 Compound 15d, 36 mg (69 %) was obtained by following general procedure B for synthesis of tetrahydro naphthyridones using 27 mg 2-aminoethanol as amine. IR λ 1646; 1 H NMR (CDCl 3 ) δ 13.24 (bs, 1H), 6H), 5H), 4.14 (d, J = 17.3 Hz, 1H), 1H), 3.66 (dd, J = 8.5, 4.2 Hz, 1H), 1H), 3.45 (d, J = 17.3 Hz, 1H), 2.90 (dd, J = 18.0, 8.5 Hz, 1H), 1H) , 2.73 (dd, J = 18.0, 4.2 Hz, 1H), 2.38-2.28 (m, 1H); 13 C NMR (CDCl 3 ) δ 162. 5, 146.2, 141.2, 136.1, 130.8, 129 .6 (2C), 128.9 (2C), 128.7 (2C), 128.2 (2C), 127.9, 127.7, 124.3, 122.4, 63.3, 58.5, 55.7, 49.6, 36.6; HRMS calcd for C 22 122.3, 61.5, 48.6, 41.9, 38.9, 21.5, 12.7; HRMS calcd for C 23 H 25 N 2 O [M+H]: 345.1967, found: 345.1973 . -7-((1S)-1-phenyl-ethyl)-5,6,7,8-tetrahydro-2H-[2,7] naphthyridine-1one (15f) Compound 15f, 14 mg (23 %) of the first eluting diastereomer and 16 mg (26 %) of the second eluting diastereomer were obtained by following general procedure B for synthesis of tetrahydro naphthyridones using 55 mg (S)-1-α-phenyl ethylamine as amine. First eluting diastereomer: IR λ 1646; 1 H NMR (CDCl 3 ) δ 12.84 (bs, 1H), 7.48-7.40 (m, 4H), 7.37-7.26 (m, 8H), 7.23-7.17 (m, 3H), 7.12 (s, 1H) , 4.00 (q, J = 6.8 Hz, 1H), 3.85 (dd, J = 8.9, 3.8 Hz, 1H), 3.67-3.55 (m, 2H), 2.93 (dd, J = 17.8, 8.9 Hz, 1H), 2.66 (dd, J = 17.8, 3.8 Hz, 1H), 1.29 (d, J = 6.8 Hz, 3H); 13 C NMR (CDCl 3 ) δ 162. 6, 145.9, 143.8, 142.4, 136.4, 130.3, 129 .6 (2C), 128.8 (2C), 128.6 (2C), 128.3 (2C), 128.2 (2C), 127.8 (2C), 127.6, 127.5, 126.7, 125.5, 122.3, 60.4, 56.0, 42.5, 37.6, 10.5 ; HRMS calcd for S14 C 28 H 27 N 2 O [M+H]: 407.2123, found: 407.2126. Second eluting diastereomer: IR λ 1644; 1 H NMR (CDCl 3 ) δ 13.13 (bs, 1H), 7.36-7.27 (m, 10H), 7.26-7.18 (m, 4H), 7.16-7.11 (m, 2H) , 3.91-3.70 (m, 4H), 2.89 (dd, J = 18.2, 5.7 Hz, 1H), 2.67 (dd, J = 18.2, 5.2 Hz, 1H), 1.47 (d, J = 6.9 Hz, 3H); 13 C NMR (CDCl 3 ) δ 162. 7, 146.0, 142.8, 140.9, 136.4, 130.5, 129.6 (2C) , 128.6 (4C), 128.5 (2C), 128.4 (2C), 128.1 (2C), 127.6, 127.4, 127.1, 125.5, 122.4, 58.8, 58.1, 42.6, 36.2, 21.5; HRMS calcd for C 28 145.9, 145.8, 141.0, 135.9, 131.2, 129.5 (2C), 128.6 (2C), 128.5 (2C), 127.8, 127.2, 126.7 (2C), 124.5, 122.6, 116.7, 116.6, 115.8, 115.6, 57.6, 44.0, 33.9 
6-Isopropyl
4,6-
7-
7-(2-
4,6-Diphenyl
